Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer:
PRS-10-262
Artikelname: |
Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal |
Artikelnummer: |
PRS-10-262 |
Hersteller Artikelnummer: |
10-262 |
Alternativnummer: |
PRS-10-262-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Humanized / CD4 D3 domain [Homo sapiens] |
Konjugation: |
Unconjugated |
Alternative Synonym: |
Hu5A8,TMB-355,TNX-355 |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
Puffer: |
PBS buffer pH7.5 |
Quelle: |
CHO cells |
Application Verdünnung: |
Optimal dilutions for each application to be determined by the researcher. |